K202334

Substantially Equivalent

Neuronaute

Applicant: Bioserenity Sas
Product code: GWQ
Advisory panel: Neurology
Date received: 2020-08-17
Decision date: 2020-12-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Paris, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.